Theravance Biopharma Inc reports results for the quarter ended in March - Earnings Summary

Theravance Biopharma

06/05/2022 20:20

* Theravance Biopharma Inc  TBPH.OQ  reported a quarterly
adjusted
loss of 22 cents​​ per share for the quarter ended in March. The
mean expectation of six analysts for the quarter was for a loss
of 11 cents per share.
    * Revenue fell 7.4% to $13.20 million from a year ago; 
analysts
expected $14.48 million. 
    * Theravance Biopharma Inc's reported EPS for the quarter
was a
loss of 34 cents​.
    * The mean earnings estimate of analysts had fallen by
about 4,718.2% in the last three months.​ 
    * In the last 30 days one analyst negatively revised an
earnings
estimate 
    * Theravance Biopharma Inc shares had risen by 1.8% this
quarter and lost 11.9% so far this year.
    * The company reported a quarterly loss of $25.95 million.
    * Wall Street's median 12-month price target for Theravance
Biopharma Inc is $10.00 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and 2 "sell" or "strong sell." 

This summary was machine generated May 6 at 07:20 p.m.  ​All
figures in US dollars unless otherwise stated